HeLa In Vitro Cellular Senescence Assay (Senescence)

CAT#: ITS-1022-YF5193
Target Cell Organism: Human
Target Cell Name: HeLa
Assay Type: Cellular Senescence in Cancer Assays
Assay Overview
This assay is to provide HeLa-based In Vitro Cellular Senescence Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
HeLa
Target Cell Organism
Human
Target Cell Background
In 1952, HeLa cells became the first human cell line that could grow and divide endlessly in a laboratory, leading scientists to label these cells "immortal". The immortality of HeLa cells contributed to their adoption across the world as the human cell line of choice for biomedical research.
Related Diseases
Cervical Cancer
Research Area
Oncology
Assay Name
In Vitro Cellular Senescence Assay (Senescence)
Short Description
HeLa-cell based In Vitro Cellular Senescence Assay (Senescence)
Assay Description
Although numbers of various oncogenes and tumor suppressor genes have been proven to regulate senescence in normal cells, evading cellular senescence appears to be a significant step in cancer. Lysosomal senescence-associated β-galactosidase (SA-β-gal) is one of the common markers used to identify
senescent cells. Senescence-associated secretory phenotype (SASP) secretion is a characteristic of senescent cells and several cytokines (interleukins 6 and 8), proteases (stromelysin-1), growth factors (vascular endothelial growth factor [VEGF]) and ECM components are some of the examples for SASPs. During early stages, SASP components help to promote migration of effector immune cells, tissue repair and release of proteases and growth factors. p53, pRb signaling (ALDH1A3, CCNA2 and AKT1) and some cell cycle genes (CDK4, CDK6 and CDK4) have been identified as genes controlling cellular senescence.
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.
Assay Subtype
Cellular Senescence Assay
For Research Use Only | Not For Clinical Use
Online Inquiry